Clonidine is a centrally acting antihypertensive agent used for the treatment of moderate to severe hypertension; it is also used for the management of migraine headaches, menopausal hot flashes, dysmenorrhea, and opioid withdrawal symptoms. The U.S. Food and Drug Administration (FDA) has approved clonidine hydrochloride extended-release tablets (0.1 mg and 0.2 mg) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years, either as monotherapy or in combination with stimulants.